Mesoblast reaches target of 300 trial patients
Mesoblast (ASX:MSB) has treated 300 patients in a key clinical trial to validate a new low back pain therapy.
Mesoblast (ASX:MSB) has treated 300 patients in a key clinical trial to validate a new low back pain therapy.
Federal Treasurer Jim Chalmers blocks voting rights for three foreign shareholders in Northern Minerals (ASX:NTU) following a failure to comply with federal divestment orders.
Residential builder Tamawood (ASX:TWD) announced it expects its unaudited full-year profit before tax to rise 40% to $11.7 million.
Aeris Resources (ASX:AIS) achieved a total group copper equivalent production of 42.1kt for the 2026 financial year.
Macro Metals (ASX:M4M) has agreed to buy the Yandi South Project for $6.5 million to boost its iron ore assets.
Tinybeans Group (ASX:TNY) permanently appointed Tracy Cho as CEO on July 14 after a five-month interim tenure.
Origin Energy (ASX:ORG) will refund over $270,000 to more than 4,500 Australian consumers following a regulatory probe.
Neurotech International (ASX:NTI) executed an agreement to issue 19.5 million unlisted options for clinical and corporate support services.
Genesis Minerals (ASX:GMD) executed an agreement to merge with Vault Minerals (ASX:VAU) in a transaction creating a combined gold company.
Vection Technologies (ASX:VR1) secured a $3.2 million order from Italian enterprise information technology services firm Retelit Digital Services.
MLG Oz (ASX:MLG) executed a binding agreement to establish a 50/50 joint venture with Mick Murray Welding.
Coronado Global Resources (ASX:CRN) appointed CFO Barrie van der Merwe as CEO, effective Aug. 1.